XML 47 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Financial Instruments (Tables)
9 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at March 31, 2024:

TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
 (in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion$30,995 $30,995 $ 
Interest rate swap agreement3,032  3,032 
Foreign currency hedge27  27 
Total assets at fair value$34,054 $30,995 $3,059 
Liabilities:
Deferred compensation plan investments, current and non-current portion$31,005 $31,005 $ 
Forward foreign currency exchange contracts15  15 
Total liabilities at fair value$31,020 $31,005 $15 

The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at June 30, 2023:
TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
 (in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion$28,209 $28,209 $— 
Forward foreign currency exchange contracts— 
Foreign currency hedge100 — 100 
Interest rate swap agreement4,687 — 4,687 
Total assets at fair value$32,997 $28,209 $4,788 
Liabilities:
Deferred compensation plan investments, current and non-current portion$28,229 $28,229 $— 
Total liabilities at fair value$28,229 $28,229 $—